PYXS Pyxis Oncology, Inc. - Common Stock
$3,38
Precio · Ago 19, 2026
Fundamentales a fecha de Ago 13, 2026
Rango 52S
$1–$6
52% of range
Calificación del Analista
STRONG BUY
15 analysts
Precio Objetivo
$7
+114% upside
P/E (TTM)
-2.6
ROE
-112.9%
Margen de Beneficio Neto
-574.5%
PYXS Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$3.38
Capitalización Bursátil
$212M
P/E (TTM)
-2.6
BPA (TTM)
$-1.28
Ingresos (TTM)
$14M
Rendimiento div.
—
ROE
-112.9%
Deuda/Capital
—
Rango 52S
$1 – $6
PYXS Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$14M
2024-12-31
→
2025-12-31
BPA
$-1.28
2021-12-31
→
2025-12-31
Flujo de caja libre
$-64M
2021-12-31
→
2025-12-31
Márgenes
-574.5%
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
PYXS
Mediana de Pares
P/E (TTM)
-2.6
1.2
P/S (TTM) (P/V (TTM))
15.3
18.5
P/B (P/C)
4.0
1.6
Price / FCF (Precio / FCF)
-3.3
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
PYXS
Mediana de Pares
Operating Margin (Margen Operativo)
-609.2%
—
Net Profit Margin (Margen de Beneficio Neto)
-574.5%
-411.2%
ROA
-64.0%
-47.1%
ROE
-112.9%
-78.9%
ROIC
-160.9%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
PYXS
Mediana de Pares
Current Ratio (Ratio corriente)
3.4
6.6
Quick Ratio (Ratio Rápido)
3.2
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
PYXS
Mediana de Pares
Revenue YoY (Ingresos interanuales)
-14.2%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
PYXS
Mediana de Pares
PYXS Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
15 analistas
- Compra fuerte 7 46,7%
- Compra 6 40,0%
- Mantener 2 13,3%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
9 analistas · 2026-08-16
Mediana
$7.00
← Por Debajo de Todos los Objetivos
$3.38
Mín
$5.00
Máx
$12.00
Objetivo mediano
$7.00
+107,1%
Objetivo medio
$7.22
+113,7%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
0.03%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 31 de marzo de 2026 | $-0.37 | $-0.38 | 0.01% |
| 31 de diciembre de 2025 | $-0.29 | $-0.34 | 0.05% |
| 30 de septiembre de 2025 | $-0.35 | $-0.35 | -0.00% |
| 30 de junio de 2025 | $-0.30 | $-0.36 | 0.06% |
| 31 de marzo de 2025 | $-0.35 | $-0.30 | -0.05% |
| 31 de diciembre de 2024 | $-0.25 | $-0.34 | 0.09% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| PYXS | $72M | -0.9 | -14.2% | -574.5% | -112.9% | — |
| ELDN | $114M | -2.9 | — | — | -69.4% | — |
| ALXO | $61M | -0.6 | — | — | -225.0% | — |
| SRZN | — | — | — | — | — | — |
| ZSQR | — | — | — | — | — | — |
| ARCT | $174M | -2.6 | -46.1% | -80.2% | -29.6% | — |
| IVVD | $697M | -8.2 | 110.5% | -98.2% | -36.9% | — |
| SION | $1.84B | -21.9 | — | — | -23.4% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 15
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Revenue | $14M | $16M | |
| Cost of Revenue | $2M | $475.0K | |
| R&D Expense | $74M | $59M | |
| SG&A Expense | $22M | $25M | |
| Operating Income | $-84M | $-89M | |
| Interest Income | $650.0K | $930.0K | |
| Other Non-op | $6M | $10M | |
| Pretax Income | $-78M | $-79M | |
| Income Tax | $1M | $-2M | |
| Net Income | $-80M | $-77M | |
| EPS (Basic) | $-1.28 | $-1.32 | |
| EPS (Diluted) | $-1.28 | $-1.32 | |
| Shares (Basic) | 62,143,166 | 58,445,765 | |
| Shares (Diluted) | 62,143,166 | 58,445,765 | |
| EBITDA | $-80M | $-86M |
Balance general 23
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $15M | $19M | |
| Short-term Investments | $51M | $107M | |
| Prepaid Expense | $4M | $4M | |
| Other Current Assets | $626.0K | $434.0K | |
| Current Assets | $72M | $132M | |
| PP&E (Net) | $8M | $10M | |
| PP&E (Gross) | $15M | $15M | |
| Accum. Depreciation | $7M | $5M | |
| Intangibles | $0 | $3M | |
| Total Assets | $92M | $157M | |
| Accounts Payable | $11M | $5M | |
| Accrued Liabilities | $9M | $11M | |
| Current Liabilities | $21M | $18M | |
| Capital Leases | $17M | $19M | |
| Deferred Tax | · | $0 | |
| Total Liabilities | $38M | $36M | |
| Common Stock | $63.0K | $60.0K | |
| Paid-in Capital | $496M | $484M | |
| Retained Earnings | $-443M | $-364M | |
| AOCI | $53.0K | $170.0K | |
| Stockholders' Equity | $53M | $121M | |
| Liabilities + Equity | $92M | $157M | |
| Shares Outstanding | 62,690,229 | 59,967,814 |
Flujo de Efectivo 11
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| D&A | $5M | $3M | |
| Stock-based Comp | $12M | $13M | |
| Deferred Tax | $0 | $-2M | |
| Other Non-cash | $-193.0K | $4M | |
| Operating Cash Flow | $-64M | $-58M | |
| CapEx | $9.0K | $237.0K | |
| Investing Cash Flow | $59M | $8M | |
| Financing Cash Flow | $594.0K | $59M | |
| Net Change in Cash | $-4M | $10M | |
| Taxes Paid | $1M | $164.0K | |
| Free Cash Flow | $-64M | $-58M |
Rentabilidad 7
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Operating Margin | -609.2% | -554.1% | |
| Net Margin | -574.5% | -479.0% | |
| Pretax Margin | -564.6% | -492.3% | |
| EBITDA Margin | -576.6% | -535.6% | |
| ROA | -64.0% | -46.7% | |
| ROE | -112.9% | -56.4% | |
| ROIC | -160.9% | -72.1% |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 3.4 | 7.5 | |
| Quick Ratio | 3.2 | 7.2 |
Eficiencia 1
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 |
Tasas de Crecimiento 1
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Revenue YoY | -14.2% | · |
Valoración (TTM) 10
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $14M | $16M | |
| Net Income TTM | $-80M | $-77M | |
| Market Cap | $72M | $94M | |
| P/E | -0.9 | -1.2 | |
| P/S | 5.2 | 5.8 | |
| P/B | 1.3 | 0.8 | |
| P / Tangible Book | 1.3 | 0.8 | |
| P / Cash Flow | -1.1 | -1.6 | |
| P / FCF | -1.1 | -1.6 | |
| Earnings Yield | -111.3% | -84.6% |
Estado de resultados 16
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $11M | $0 | $3M | · | $0 | $0 | $0 | $16M | |
| Cost of Revenue | · | · | · | · | · | · | $0 | $0 | $0 | $475.0K | |
| R&D Expense | $16M | $20M | $22M | $18M | $17M | $17M | $14M | $18M | $14M | $13M | |
| SG&A Expense | $10M | $4M | $5M | $6M | $5M | $6M | $5M | $6M | $6M | $8M | |
| Operating Expenses | $26M | $24M | · | · | $23M | $23M | · | · | · | · | |
| Operating Income | $-26M | $-24M | $-18M | $-23M | $-20M | $-23M | $-40M | $-24M | $-20M | $-6M | |
| Interest Income | $61.0K | $218.0K | $225.0K | $242.0K | $99.0K | $84.0K | $87.0K | $194.0K | $387.0K | $262.0K | |
| Other Non-op | $644.0K | $1M | $1M | $1M | $2M | $2M | $2M | $3M | $3M | $2M | |
| Pretax Income | $-25M | · | $-17M | $-22M | $-18M | · | $-38M | $-21M | $-17M | · | |
| Income Tax | $0 | · | $1M | $0 | $283.0K | · | · | · | · | · | |
| Net Income | $-25M | $-23M | $-18M | $-22M | $-18M | $-21M | $-36M | $-21M | $-17M | $-3M | |
| EPS (Basic) | $-0.40 | $-0.37 | $-0.28 | $-0.35 | $-0.30 | $-0.35 | $-0.62 | $-0.35 | $-0.29 | $-0.06 | |
| EPS (Diluted) | $-0.40 | $-0.37 | $-0.28 | $-0.35 | $-0.30 | $-0.35 | $-0.62 | $-0.35 | $-0.29 | $-0.06 | |
| Shares (Basic) | 63,991,609 | 63,469,850 | -123,381,994 | 62,557,386 | 61,918,826 | 61,048,948 | -114,054,235 | 60,715,041 | 60,495,675 | 51,289,284 | |
| Shares (Diluted) | 63,991,609 | 63,469,850 | -123,381,994 | 62,557,386 | 61,918,826 | 61,048,948 | -114,054,235 | 60,715,041 | 60,495,675 | 51,289,284 | |
| EBITDA | $-26M | $-24M | · | $-23M | $-20M | $-22M | · | $-24M | $-20M | $-4M |
Balance general 24
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $6M | $15M | $9M | $11M | $13M | $19M | $12M | $25M | $28M | |
| Short-term Investments | $14M | $35M | $51M | $67M | $78M | $93M | $107M | $133M | $131M | $129M | |
| Receivables | · | · | · | · | $3M | · | · | · | · | $8M | |
| Prepaid Expense | $2M | $3M | $4M | $5M | $7M | $5M | $4M | $3M | $4M | $6M | |
| Other Current Assets | · | · | $626.0K | · | · | · | $434.0K | · | · | · | |
| Current Assets | $37M | $46M | $72M | $83M | $100M | $112M | $132M | $149M | $161M | $172M | |
| PP&E (Net) | $7M | $8M | $8M | $8M | $9M | $9M | $10M | $10M | $11M | $11M | |
| PP&E (Gross) | · | · | $15M | · | · | · | $15M | · | · | · | |
| Accum. Depreciation | · | · | $7M | · | · | · | $5M | · | · | · | |
| Intangibles | · | · | $0 | $2M | $2M | $3M | $3M | $24M | $24M | $24M | |
| Total Assets | $55M | $64M | $92M | $106M | $123M | $136M | $157M | $195M | $208M | $220M | |
| Accounts Payable | $3M | $5M | $11M | $10M | $9M | $3M | $5M | $5M | $5M | $2M | |
| Accrued Liabilities | $12M | $10M | $9M | $8M | $7M | $10M | $11M | $14M | $10M | $11M | |
| Current Liabilities | $27M | $17M | $21M | $19M | $18M | $14M | $18M | $20M | $17M | $14M | |
| Capital Leases | $16M | $16M | $17M | $17M | $18M | $18M | $19M | $19M | $19M | $20M | |
| Deferred Tax | · | · | · | · | · | · | · | $2M | $2M | $2M | |
| Total Liabilities | $43M | $33M | $38M | $37M | $36M | $33M | $36M | $42M | $39M | $36M | |
| Common Stock | $63.0K | $63.0K | $63.0K | $62.0K | $62.0K | $62.0K | $60.0K | $59.0K | $59.0K | $59.0K | |
| Paid-in Capital | $503M | $498M | $496M | $494M | $491M | $488M | $484M | $481M | $477M | $474M | |
| Retained Earnings | $-492M | $-466M | $-443M | $-425M | $-403M | $-385M | $-364M | $-328M | $-307M | $-289M | |
| AOCI | $-4.0K | $0 | $53.0K | $69.0K | $-5.0K | $49.0K | $170.0K | $351.0K | $-102.0K | $-60.0K | |
| Stockholders' Equity | $11M | $31M | $53M | $69M | $88M | $103M | $121M | $154M | $170M | $184M | |
| Liabilities + Equity | $55M | $64M | $92M | $106M | $123M | $136M | $157M | $195M | $208M | $220M | |
| Shares Outstanding | 63,434,936 | 62,831,246 | 62,690,229 | 62,149,664 | 62,018,135 | 61,631,376 | 59,967,814 | 59,449,998 | 58,914,712 | 58,803,126 |
Flujo de Efectivo 9
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $301.0K | $459.0K | $3M | $527.0K | $535.0K | $552.0K | $550.0K | $731.0K | $585.0K | $1M | |
| Stock-based Comp | $6M | $1M | $2M | $3M | $3M | $4M | $3M | $3M | $3M | $4M | |
| Other Non-cash | · | $-4M | · | · | · | $-6M | · | · | · | $-23M | |
| Operating Cash Flow | $-18M | $-26M | $-10M | $-13M | $-17M | $-23M | $-19M | $-15M | $-3M | $-21M | |
| CapEx | · | · | $0 | · | · | · | $0 | $0 | $0 | $237.0K | |
| Investing Cash Flow | $21M | $16M | $16M | $11M | $15M | $16M | $27M | $-8.0K | $4.0K | $-18M | |
| Financing Cash Flow | $10M | $-25.0K | $669.0K | $-8.0K | $-67.0K | $0 | $50.0K | $2M | $110.0K | $58M | |
| Net Change in Cash | $13M | $-10M | $7M | $-2M | $-2M | $-7M | $7M | $-13M | $-3M | $18M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-21M |
Rentabilidad 7
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -700.4% | · | · | · | · | -34.7% | |
| Net Margin | · | · | · | · | -650.9% | · | · | · | · | -20.2% | |
| Pretax Margin | · | · | · | · | -640.8% | · | · | · | · | · | |
| EBITDA Margin | · | · | · | · | -700.4% | · | · | · | · | -27.8% | |
| ROA | -28.5% | -23.2% | · | -14.6% | -11.1% | -11.9% | · | -11.1% | -9.0% | -1.6% | |
| ROE | -51.2% | -34.6% | · | -19.8% | -14.3% | -14.7% | · | -14.5% | -11.0% | -1.9% | |
| ROIC | -227.2% | · | · | · | -22.9% | · | · | · | · | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 2.8 | · | 4.3 | 5.7 | 7.8 | · | 7.3 | 9.5 | 12.2 | |
| Quick Ratio | 1.2 | 2.5 | · | 3.9 | 5.2 | 7.3 | · | 7.1 | 9.2 | 11.7 |
Eficiencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 0.0 | · | · | · | · | 0.1 | |
| Receivables Turnover | · | · | · | · | 1.9 | · | · | · | · | 4.0 |
Valoración (TTM) 8
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-89M | $-85M | · | $-83M | $-78M | $-63M | · | $-65M | $-60M | $-61M | |
| Market Cap | $191M | $92M | · | $138M | $68M | $60M | · | $218M | $195M | $251M | |
| P/E | -2.1 | -1.1 | · | -1.6 | -0.9 | -0.9 | · | -2.9 | -2.5 | -2.7 | |
| P/B | 16.7 | 2.9 | · | 2.0 | 0.8 | 0.6 | · | 1.4 | 1.1 | 1.4 | |
| P / Tangible Book | 16.7 | 2.9 | · | 2.1 | 0.8 | 0.6 | · | 1.7 | 1.3 | 1.6 | |
| P / Cash Flow | · | -3.5 | · | · | · | -2.7 | · | · | · | -12.1 | |
| P / FCF | · | · | · | · | · | · | · | · | · | -12.0 | |
| Earnings Yield | -47.2% | -93.8% | · | -60.8% | -117.3% | -107.1% | · | -34.3% | -39.9% | -36.9% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ingresos | $14M | $16M | — | — | — |
| Margen Operativo % | -609.2% | -554.1% | — | — | — |
| Beneficio neto | $-80M | $-77M | $-74M | $-121M | $-76M |
| EPS Diluido | $-1.28 | $-1.32 | $-1.85 | $-3.65 | $-8.95 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | 3.4 | 7.5 | 4.8 | — | 14.9 |
| Ratio Rápido | 3.2 | 7.2 | 4.6 | — | 14.7 |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $-64M | $-58M | $-77M | — | $-36M |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 89 declarantes · $93.5M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 16 (+1 vs trimestre anterior) | 9 (-2 vs trimestre anterior) | 22 (+10 vs trimestre anterior) | 24 (-11 vs trimestre anterior) | +6.4M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| GordonMD Global Investments LP | $30 174 976 | 10 024 909 | 32,28% | Acciones |
| Pfizer Inc | $16 487 769 | 5 952 263 | 17,64% | Acciones |
| Laurion Capital Management LP | $14 751 673 | 4 900 888 | 15,78% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $6 248 751 | 2 075 997 | 6,68% | Acciones |
| Atle Fund Management AB | $2 909 041 | 966 459 | 3,11% | Acciones |
| Palo Alto Investors LP | $2 601 474 | 864 277 | 2,78% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $2 324 418 | 772 232 | 2,49% | Acciones |
| Woodline Partners LP | $1 577 237 | 523 999 | 1,69% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $1 438 803 | 477 598 | 1,54% | Acciones |
| 683 Capital Management, LLC | $1 382 695 | 459 367 | 1,48% | Acciones |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $1 290 104 | 428 606 | 1,38% | Acciones |
| DIADEMA PARTNERS LP | $1 168 482 | 388 200 | 1,25% | Opción de compra |
| Longaeva Partners L.P. | $1 064 282 | 353 582 | 1,14% | Acciones |
| Decheng Capital LLC | $983 698 | 326 810 | 1,05% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $911 988 | 302 986 | 0,98% | Acciones |
| STATE STREET CORP | $748 999 | 248 837 | 0,80% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $701 342 | 233 004 | 0,75% | Acciones |
| JANE STREET GROUP, LLC | $534 594 | 177 606 | 0,57% | Acciones |
| Bank of New York Mellon Corp | $384 233 | 127 652 | 0,41% | Acciones |
| NORTHERN TRUST CORP | $373 117 | 123 959 | 0,40% | Acciones |
| NewEdge Wealth, LLC | $349 178 | 116 006 | 0,37% | Acciones |
| VANGUARD GROUP INC | $346 032 | 300 897 | 0,37% | Acciones |
| XTX Topco Ltd | $333 926 | 110 939 | 0,36% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $252 723 | 83 961 | 0,27% | Acciones |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $244 593 | 81 260 | 0,26% | Acciones |
| BANK OF AMERICA CORP /DE/ | $242 197 | 80 464 | 0,26% | Acciones |
| JANE STREET GROUP, LLC | $221 837 | 73 700 | 0,24% | Opción de compra |
| Cable Car Capital, LP | $185 434 | 61 606 | 0,20% | Acciones |
| MYDA Advisors LLC | $150 500 | 50 000 | 0,16% | Acciones |
| Qube Research & Technologies Ltd | $150 295 | 49 932 | 0,16% | Acciones |
| UNIVERSITY OF CHICAGO | $146 680 | 48 731 | 0,16% | Acciones |
| CITADEL ADVISORS LLC | $142 424 | 47 317 | 0,15% | Acciones |
| Quadrature Capital Ltd | $141 672 | 47 067 | 0,15% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $139 062 | 46 200 | 0,15% | Opción de compra |
| GOLDMAN SACHS GROUP INC | $138 159 | 45 900 | 0,15% | Acciones |
| Verdad Advisers, LP | $135 146 | 44 899 | 0,14% | Acciones |
| LPL Financial LLC | $131 098 | 43 554 | 0,14% | Acciones |
| COMMONWEALTH EQUITY SERVICES, LLC | $127 790 | 42 455 | 0,14% | Acciones |
| J. Derek Lewis & Associates Inc. | $126 420 | 42 000 | 0,14% | Acciones |
| CITIGROUP INC | $114 997 | 38 205 | 0,12% | Acciones |
| SIMPLEX TRADING, LLC | $114 085 | 37 902 | 0,12% | Acciones |
| Point72 Asset Management, L.P. | $111 647 | 37 092 | 0,12% | Acciones |
| Walleye Capital LLC | $110 702 | 36 778 | 0,12% | Acciones |
| Nuveen Asset Management, LLC | $95 378 | 61 140 | 0,10% | Acciones |
| MARSHALL WACE, LLP | $89 613 | 29 772 | 0,10% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $82 426 | 27 384 | 0,09% | Acciones |
| MACKENZIE FINANCIAL CORP | $79 292 | 26 343 | 0,08% | Acciones |
| Cetera Investment Advisers | $75 250 | 25 000 | 0,08% | Acciones |
| Cubist Systematic Strategies, LLC | $73 395 | 33 061 | 0,08% | Acciones |
| Graham Capital Management, L.P. | $68 351 | 22 708 | 0,07% | Acciones |
| Vanguard Global Advisers, LLC | $63 938 | 21 242 | 0,07% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $56 889 | 18 900 | 0,06% | Opción de venta |
| OSAIC HOLDINGS, INC. | $53 339 | 17 721 | 0,06% | Acciones |
| GROUP ONE TRADING LLC | $49 605 | 16 480 | 0,05% | Acciones |
| CITADEL ADVISORS LLC | $44 247 | 14 700 | 0,05% | Opción de compra |
| Point72 Asia (Singapore) Pte. Ltd. | $40 087 | 18 057 | 0,04% | Acciones |
| FMR LLC | $35 801 | 11 894 | 0,04% | Acciones |
| PACES FERRY WEALTH ADVISORS, LLC | $34 434 | 11 440 | 0,04% | Acciones |
| BlackRock, Inc. | $33 941 | 11 276 | 0,04% | Acciones |
| NewEdge Advisors, LLC | $30 853 | 10 250 | 0,03% | Acciones |
| China Universal Asset Management Co., Ltd. | $30 350 | 10 083 | 0,03% | Acciones |
| Tower Research Capital LLC (TRC) | $28 288 | 9 398 | 0,03% | Acciones |
| MERCER GLOBAL ADVISORS INC /ADV | $27 542 | 9 150 | 0,03% | Acciones |
| TWO SIGMA ADVISERS, LP | $26 018 | 22 624 | 0,03% | Acciones |
| PNC Financial Services Group, Inc. | $19 565 | 6 500 | 0,02% | Acciones |
| Persistent Asset Partners Ltd | $16 796 | 224 | 0,02% | Opción de compra |
| JPMORGAN CHASE & CO | $15 081 | 5 273 | 0,02% | Acciones |
| HAGER INVESTMENT MANAGEMENT SERVICES, LLC | $15 050 | 5 000 | 0,02% | Acciones |
| Federation des caisses Desjardins du Quebec | $13 545 | 4 500 | 0,01% | Acciones |
| BARCLAYS PLC | $12 314 | 4 091 | 0,01% | Acciones |
| FEDERATED HERMES, INC. | $8 916 | 2 962 | 0,01% | Acciones |
| Mirae Asset Global Investments Co., Ltd. | $8 527 | 2 833 | 0,01% | Acciones |
| UBS Group AG | $8 428 | 2 800 | 0,01% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $8 094 | 2 689 | 0,01% | Acciones |
| FIRST UNITED BANK & TRUST | $7 375 | 2 500 | 0,01% | Acciones |
| GF FUND MANAGEMENT CO. LTD. | $3 690 | 1 226 | 0,00% | Acciones |
| NISA INVESTMENT ADVISORS, LLC | $2 893 | 961 | 0,00% | Acciones |
| Physician Wealth Advisors, Inc. | $2 839 | 943 | 0,00% | Acciones |
| SBI Securities Co., Ltd. | $1 532 | 509 | 0,00% | Acciones |
| JONES FINANCIAL COMPANIES LLLP | $1 385 | 500 | 0,00% | Acciones |
| MORGAN STANLEY | $1 054 | 350 | 0,00% | Acciones |
| WELLS FARGO & COMPANY/MN | $858 | 285 | 0,00% | Acciones |
| STIFEL FINANCIAL CORP | $713 | 237 | 0,00% | Acciones |
| Cornerstone Financial Management LLC | $518 | 172 | 0,00% | Acciones |
| ACADIAN ASSET MANAGEMENT LLC | $380 | 126 793 | 0,00% | Acciones |
| Caitong International Asset Management Co., Ltd | $105 | 35 | 0,00% | Acciones |
| CWM, LLC | $50 | 34 | 0,00% | Acciones |
| Arax Advisory Partners | $42 | 14 | 0,00% | Acciones |
| Winthrop Capital Management, LLC | $9 | 6 000 | 0,00% | Acciones |
Informantes de la empresa 16 insiders · 7 directivos · 8 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Lara Sullivan, M.D. | President ,CEO & CMO | 31 de marzo de 2025 A | 2 403 882 | 0 | 0 | $0 |
| Connealy Pamela Yanchik | CFO & COO | 31 de marzo de 2025 A | 1 199 143 | 0 | 0 | $0 |
| Ritu Shah | Chief Operating Officer | 7 de octubre de 2021 A | — | 0 | 0 | $0 |
| Jitendra Wadhane | Prin Fin & Acct Officer | 24 de marzo de 2026 A | 512 882 | 0 | 0 | $0 |
| Ken Kobayashi | Chief Medical Officer | 29 de diciembre de 2023 A | — | 0 | 0 | $0 |
| Jay Feingold | Chief Medical Officer | 24 de marzo de 2023 A | 730 345 | 0 | 0 | $0 |
| Ronald Herbst | Chief Scientific Officer | 7 de octubre de 2021 A | — | 0 | 0 | $0 |
| Jakob Dupont | Consejero | 30 de junio de 2026 M | 38 741 | 0 | 1 | $-107 100 |
| Santhosh Palani | Consejero | 24 de marzo de 2026 A | 6 000 | 0 | 0 | $0 |
| Darren S Cline | Consejero | 24 de marzo de 2026 A | 251 405 | 0 | 0 | $0 |
| Rachel Humphrey | Consejero | 24 de marzo de 2026 A | 81 309 | 0 | 3 | $-15 865 |
| Michael A Metzger | Consejero | 24 de marzo de 2026 A | — | 0 | 0 | $0 |
| Freda C Lewis-Hall | Consejero | 24 de marzo de 2026 A | 241 405 | 0 | 0 | $0 |
| John L Flavin | Consejero | 24 de marzo de 2026 A | 413 015 | 0 | 0 | $0 |
| Thomas Civik | — | 12 de agosto de 2026 A | 206 186 | 0 | 0 | $0 |
| Mark Chin | — | 21 de abril de 2022 S | 0 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 2 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Lara Sullivan, M.D. ×2 presentaciones | 2 de abril de 2025 | 11,21% | Enmienda | — | SEC |
| Lara Sullivan ×4 presentaciones | 3 de abril de 2024 | — | Presentación inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 6 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| BIB · ProShares Trust | 0,01% | 2 303 NS | 31 de mayo de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15 de julio de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 de julio de 2026 | Diario |
| IBB · iShares Trust | — | — | 18 de agosto de 2026 | Diario |
| IWC · iShares Trust | — | — | 18 de agosto de 2026 | Diario |
| IBBQ · Invesco Exchange-Traded Fund Trust … | — | — | 17 de agosto de 2026 | Diario |